| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |